Open Label Extensions
Open Label Extensions (OLEs) allow companies to provide continuation of treatment for prior clinical trial patients and collect more scientific data on their drug.
We recognize the importance of continuation of our customer’s clinical trial into an OLE, supplying much needed trial medication to patients who took part in the main study
OLEs are not as stringent or intensive as the main trial itself, so we pride our approach in being value-driven and pragmatic to ensure we deliver OLEs within budget without compromising on quality. This means that we:
- Approach OLEs from the drug delivery, safety and data collection perspective
- Combine patient retention and site support with our global distribution services
- Focus on end results and delivery of medication to the patients in need
If you:
- have any challenges or concerns about your planned OLE
- need a second opinion about how to move your trial patients on to an OLE while waiting on regulatory approval
- need ideas about using tools which will ensure quality acquisition of clinical data while downsizing from a blinded clinical trial